{"id": "glu28m", "title": "Allogene Therapeutics DD", "selftext": "The company  is  developing a pipeline of allogeneic CAR-T cell therapies to treat cancer.  This could be a game changing transformational company after it released results last week on phase 1 trial results.  The results were from only nine patients treated at the lower dose of ALLO-647. Of those patients, three achieved a complete response (CR), meaning they had no evidence of disease. \n\nThe stock has been shooting up and could likely go up further.", "created_utc": 1589773983.0, "permalink": "/r/wallstreetbets/comments/glu28m/allogene_therapeutics_dd/", "is_self": true}